| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.6 |